First substack exclusive elevator pitch.

Possible replay of $TERN

I’m doing two public pitches a year; which for 2026 are Q32 Bio and Connect Biopharma.

A benefit of substack is that I’m able to share more high conviction ideas. I don’t write for the sake of writing, but only when there is something important to say.

I’m long this current stock and with a catalyst next week, I think this is a special situation you will want to look into. Unfortunately, with my QTTB 0.00%↑ draft edging 8000 words, there isn’t the time to go into this in detail - so I’m going to give you the elevator pitch.